Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

370674 Guanosine 3ʹ,5ʹ-cyclic Monophosphorothioate, 8-Bromo-, Rp-Isomer, Sodium Salt - Calbiochem

Ficha de datos de seguridad (MSDS o SDS), certificado de análisis y de calidad (CoA y CoQ), expedientes, folletos y otros documentos disponibles.

Sinónimos: Rp-8-Br-cGMPS, Na, PKG Inhibitor II

Primary Target: PKG
370674
Purchase on Sigma-Aldrich

Descripción

Replacement Information

Tabla espec. clave

Empirical Formula
C₁₀H₁₀BrN₅O₆PS · Na

Products

Número de referenciaEmbalaje Cant./Env.
370674-5UMOL Ampolla de plást. 5 umol
Description
OverviewA potent, cell-permeable, and metabolically stable inhibitor of protein kinase G (PKG; Ki = 4 µM). Acts as a cyclic nucleotide-gated channel agonist (EC50 = 173.5 µM). Significantly more lipophilic and membrane-permeable than cGMP or Rp-cGMPS. Resistant to mammalian cyclic nucleotide-dependent phosphodiesterases. Note: 5 µmol = 2.31 mg.
Catalogue Number370674
Brand Family Calbiochem®
SynonymsRp-8-Br-cGMPS, Na, PKG Inhibitor II
References
ReferencesWei, J.Y., et al. 1998. J. Mol. Neurosci. 10, 53.
Nakamura, A., et al. 1996. Br. J. Pharmacol. 117, 407.
Van Uffelen, B.E., et al. 1996. J. Leukoc. Biol. 60, 94.
Nakazawa, M., et al. 1994. Eur. J. Pharmacol. 253, 179.
Zhuo, M., et al. 1994. Nature 368, 635.
Product Information
ATP CompetitiveN
DeclarationSold under license of Patent DE 3,802,865.4 issued to BIOLOG LSI.
FormLyophilized
Hill FormulaC₁₀H₁₀BrN₅O₆PS · Na
Chemical formulaC₁₀H₁₀BrN₅O₆PS · Na
Hygroscopic Hygroscopic
ReversibleN
Structure formula ImageStructure formula Image
Applications
Biological Information
Primary TargetPKG
Primary Target K<sub>i</sub>4 µM against protein kinase G (PKG)
Purity≥99% by HPLC
Physicochemical Information
Cell permeableY
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Ambient Temperature Only
Toxicity Standard Handling
Storage -20°C
Hygroscopic Hygroscopic
Do not freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
Packaging Information
Transport Information
Supplemental Information
Specifications

Documentation

Guanosine 3ʹ,5ʹ-cyclic Monophosphorothioate, 8-Bromo-, Rp-Isomer, Sodium Salt - Calbiochem Ficha datos de seguridad (MSDS)

Título

Ficha técnica de seguridad del material (MSDS) 

Guanosine 3ʹ,5ʹ-cyclic Monophosphorothioate, 8-Bromo-, Rp-Isomer, Sodium Salt - Calbiochem Certificados de análisis

CargoNúmero de lote
370674

Referencias bibliográficas

Visión general referencias
Wei, J.Y., et al. 1998. J. Mol. Neurosci. 10, 53.
Nakamura, A., et al. 1996. Br. J. Pharmacol. 117, 407.
Van Uffelen, B.E., et al. 1996. J. Leukoc. Biol. 60, 94.
Nakazawa, M., et al. 1994. Eur. J. Pharmacol. 253, 179.
Zhuo, M., et al. 1994. Nature 368, 635.
Ficha técnica

Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

Revision21-January-2008 JSW
SynonymsRp-8-Br-cGMPS, Na, PKG Inhibitor II
DescriptionA potent cell-permeable, metabolically stable inhibitor of cGMP-dependent protein kinase (PKG). Significantly more lipophilic and membrane-permeable than cGMP or Rp-cGMPS. Resistant to mammalian cyclic nucleotide-dependent phosphodiesterases.
FormLyophilized
Chemical formulaC₁₀H₁₀BrN₅O₆PS · Na
Structure formulaStructure formula
Purity≥99% by HPLC
SolubilityH₂O (1 mg/ml)
Storage -20°C
Hygroscopic
Do Not Freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
Toxicity Standard Handling
ReferencesWei, J.Y., et al. 1998. J. Mol. Neurosci. 10, 53.
Nakamura, A., et al. 1996. Br. J. Pharmacol. 117, 407.
Van Uffelen, B.E., et al. 1996. J. Leukoc. Biol. 60, 94.
Nakazawa, M., et al. 1994. Eur. J. Pharmacol. 253, 179.
Zhuo, M., et al. 1994. Nature 368, 635.